Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer (Q82892087)
Jump to navigation
Jump to search
scientific article published on 20 March 2006
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer |
scientific article published on 20 March 2006 |
Statements
Docetaxel, cisplatin, and trastuzumab as primary systemic therapy for human epidermal growth factor receptor 2-positive locally advanced breast cancer (English)
Judith Hurley
Philomena Doliny
Isildinha Reis
Orlando Silva
Carmen Gomez-Fernandez
Pedro Velez
Giovanni Pauletti
Jodeen E Powell
Mark D Pegram
Dennis J Slamon
20 March 2006